The 36-month beta value for BSGM is at 0.95. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BSGM is 9.29M, and currently, shorts hold a 10.35% of that float. The average trading volume for BSGM on May 01, 2024 was 1.19M shares.
BSGM) stock’s latest price update
The stock price of Biosig Technologies Inc (NASDAQ: BSGM) has jumped by 23.88 compared to previous close of 1.34. Despite this, the company has seen a gain of 12.16% in its stock price over the last five trading days. Zacks Investment Research reported 2023-08-25 that BioSig’s (BSGM) subscription model for PURE EP provides electrophysiologists and cardiology departments with flexibility.
BSGM’s Market Performance
Biosig Technologies Inc (BSGM) has seen a 12.16% rise in stock performance for the week, with a 137.14% gain in the past month and a -11.80% plunge in the past quarter. The volatility ratio for the week is 17.18%, and the volatility levels for the past 30 days are at 44.48% for BSGM. The simple moving average for the past 20 days is 28.31% for BSGM’s stock, with a -56.00% simple moving average for the past 200 days.
Analysts’ Opinion of BSGM
Many brokerage firms have already submitted their reports for BSGM stocks, with ROTH Capital repeating the rating for BSGM by listing it as a “Buy.” The predicted price for BSGM in the upcoming period, according to ROTH Capital is $9 based on the research report published on March 30, 2020 of the previous year 2020.
BSGM Trading at 93.98% from the 50-Day Moving Average
After a stumble in the market that brought BSGM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.94% of loss for the given period.
Volatility was left at 44.48%, however, over the last 30 days, the volatility rate increased by 17.18%, as shares surge +145.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +167.48% upper at present.
During the last 5 trading sessions, BSGM rose by +12.16%, which changed the moving average for the period of 200-days by -85.18% in comparison to the 20-day moving average, which settled at $1.3429. In addition, Biosig Technologies Inc saw -65.05% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BSGM starting from LONDONER KENNETH L, who purchase 15,600 shares at the price of $1.24 back on Jun 13 ’23. After this action, LONDONER KENNETH L now owns 2,507,020 shares of Biosig Technologies Inc, valued at $19,358 using the latest closing price.
LONDONER KENNETH L, the Chief Executive Officer of Biosig Technologies Inc, purchase 6,000 shares at $1.17 during a trade that took place back on Jun 12 ’23, which means that LONDONER KENNETH L is holding 2,491,420 shares at $7,040 based on the most recent closing price.
Stock Fundamentals for BSGM
Current profitability levels for the company are sitting at:
- -1584.0 for the present operating margin
- -27.06 for the gross margin
The net margin for Biosig Technologies Inc stands at -1613.5. The total capital return value is set at 10.24. Equity return is now at value -6869.27, with -983.11 for asset returns.
Based on Biosig Technologies Inc (BSGM), the company’s capital structure generated -0.18 points at debt to capital in total, while cash flow to debt ratio is standing at -38.3. The debt to equity ratio resting at -0.16. The interest coverage ratio of the stock is 7128.0.
Currently, EBITDA for the company is -28.15 million with net debt to EBITDA at -0.01. When we switch over and look at the enterprise to sales, we see a ratio of 1047.28. The receivables turnover for the company is 0.75for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.12.
Conclusion
In conclusion, Biosig Technologies Inc (BSGM) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
